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Abstract
Background: Efficient expression systems exist for antibody (Ab) molecules, which allow for characterization of
large numbers of individual Ab variants. In contrast, such expression systems have been lacking for soluble T cell
receptors (TCRs). Attempts to generate bacterial systems have generally resulted in low yields and material which is
prone to aggregation and proteolysis. Here we present an optimized periplasmic bacterial expression system for
soluble single chain (sc) TCRs.
Results: The effect of 1) over-expression of the periplasmic chaperon FkpA, 2) culture conditions and 3) molecular
design was investigated. Elevated levels of FkpA allowed periplasmic soluble scTCR expression, presumably by
preventing premature aggregation and inclusion body formation. Periplasmic expression enables disulphide bond
formation, which is a prerequisite for the scTCR to reach its correct fold. It also enables quick and easy recovery of
correctly folded protein without the need for time-consuming downstream processing. Expression without IPTG
induction further improved the periplasmic expression yield, while addition of sucrose to the growth medium
showed little effect. Shaker flask yield of mg levels of active purified material was obtained. The Vab domain
orientation was far superior to the Vba domain orientation regarding monomeric yield of functionally folded
molecules.
Conclusion: The general expression regime presented here allows for rapid production of soluble scTCRs and is
applicable for 1) high yield recovery sufficient for biophysical characterization and 2) high throughput screening of
such molecules following molecular engineering.
Background
The antigen (Ag) specific receptor of the T cell lineage,
the TCR, is a transmembrane heterodimer of covalently
coupled a- and b-polypeptide chains. Each chain con-
sists of two extracellular immunoglobulin (Ig) domains,
one variable (V) and one constant (C), and the two V
domains comprise the ligand binding portion that speci-
fically interacts with a peptide/major histocompatibility
complex (pMHC). TCRs are detection molecules with
exquisite specificity and exhibit, like Abs, an enormous
diversity. The fine tuning of the specificity, MHC
restriction and thymic selection is incompletely under-
stood. However, recent re-evaluation and comparison of
the existing pMHC/TCR crystal structures demonstrate
conservation of specific TCR-MHC contacts in com-
plexes bearing common V segments and MHC allotypes.
This has for the first time made it possible to postulate
a TCR-MHC recognition code [1-5]. However, the pre-
dictions are still based on a restricted number of crystal-
lographic data sets primarily due to the lack of a robust
and versatile expression system for soluble TCRs neces-
sary for obtaining sufficient amounts of protein. Soluble
TCRs are prone to aggregation and missfolding, and
many of the difficulties encountered may probably be
explained by the fact that TCRs, unlike Abs, have not
evolved to be secreted, but are expressed as membrane-
bound molecules that are intrinsically unstable when
expressed as soluble molecules.
Several engineering strategies for making soluble ver-
sions of TCRs, including scTCRs [6-8] and fusion of the
extracellular TCR domains to other proteins; i.e. maltose
binding protein, human constrant kappa domain (huC)
or leucine zippers [9-16] have been reported. However,
all of these strategies have shown limited success due to
low production yield, poor functionality, or lack of
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crystallization abilities [17,18]. The introduction of a
non-native disulphide bond in the TCR invariant region,
to make so called dsTCR, has greatly increased the sta-
bility and folding characteristics of more than 20 human
TCRs when expressed as cytosolic inclusion bodies that
have been refolded [19]. Even without this artificial dis-
ulphide bond, optimized bacterial inclusion body expres-
sion and refolding has so far shown the highest success
rate for obtaining soluble TCRs in high yields [20].
Recently an improved strategy for soluble periplasmic E.
coli expression based on rational mutagenesis, over-
expression of Skp, and fusion to the Ab C domain, was
reported [9]. However, all of the expression systems
described so far represents labour intensive and low
through-put avenues that require either inclusion body
denaturation and refolding [17], introduction of solubi-
lity-increasing amino acid substitutions or fusion to a
second protein which might interfere with downstream
applications [9].
The extracellular part of TCRs and Ab Fab fragments
are structurally similar. This is also the case for mole-
cules that consist of the two V domains connected by a
flexible linker, namely single chain fragment variable
(scFv) and scTCRs, respectively. E. coli expression of Ab
derived fragments has been highly successful and a
number of vector systems and expression strategies exist
([21] and references herein). These are to a large extent
based on direct targeting to the periplasm with or with-
out co-expression of chaperones, such as skp, fkp, trigger
factor and dsbC [9,22-31].
In the current report, we describe an improved peri-
plasmic expression system that allows rapid expression
of unmodified soluble scTCRs based on over-expression
of FkpA. The expression system was developed in E. coli
XL1-Blue to complement a recently reported TCR
phage display platform based on this particular host
[32]. A systematic evaluation of a variety of parameters
known to influence heterologous protein expression in
E. coli was conducted using two scTCRs derived from
the T cell clones 4B2A1 and 7A10B2 associated with a
mouse model for idiotype (Id) dependent immune regu-
lation [33-35]. Notably, these scTCRs are genetically
unrelated. The final expression and purification protocol
allowed the isolation of monomeric soluble scTCRs,
with correct native fold and apparent functional activity.
Key advantages over earlier TCR expression systems are
the ability to produce “native” TCR sequences without
previous engineering steps such as the introduction of
solubility increasing mutations or fusion proteins and
the ability to generate soluble material without refolding
strategies. This system can therefore be used as a solu-
ble expression platform downstream of a phage display
library selection, or as an initial screen of a panel of
native TCR clones to pick out the best starting point
before stability or affinity maturation engineering.
Methods
Abs and additional reagents
The mouse anti-HIS-HRP Ab was purchased from AbD
Serotec (Oxford, UK). The anti-FLAG M2-HRP Ab was
purchased from Sigma-Aldrich (Oslo, Norway). All restric-
tion enzymes were purchased from New England Biolabs
(Ipswich, MA, USA). TCR-specific mAbs were GB113 [36]
(clonotype-specific for 4B2A1), F23.1 [37] (recognizes
TRBV13), 44-22-1 [38] (recognizes TRBV19), RR4-7 [39]
(recognizes TRBV19). F23.1 and 44-22-1 were kind gifts
from Dr. Uwe D. Staerz (Department of Medicine,
National Jewish Medical and Research Center, Denver,
USA) and Dr. Hans Hengartner (Institute for Experimen-
tal Immunology, University Hospital Zurich, Zurich, Swit-
zerland), respectively. RR4-7 was purchased from BD
Pharmingen (San Diego, CA, USA). The scFv control was
a kind gift form Affitech AS (Oslo, Norway).
T cell Clones
4B2A1 and 7A10B2 T cell clones are specific for resi-
dues 91-101 of mouse Ig l2315 light chain presented on
the MHC class II I-Ed molecule [40,41]. The clones are
distinguished by the 4B2A1 not cross-reacting to a
Phe94 (mutated l2315 sequence) to Tyr94 (germline l2)
substitution while 7A10B2 does [42]. Moreover, while
4B2A1 expresses a unique TCR [TRAV7D-3*01,
TRAJ40*01/TRBV13-2*01, TRBD1*01, TRBJ1-2*01],
7A10B2 expresses a dominant and recurrent TCR
[TRAV9-3*01, TRAJ58*01/TRBV19*01, TRBD1*01,
TRBJ1-1*01] in this system [43].
Plasmids and bacterial strains
The soluble expression vectors pHOG-Dummy [44] and
pHOG21 [45] were a kind gift from Affitech AS (Oslo,
Norway). pHOG21 encodes a scFv with specificity against
2-phenyloxazol-5-one (phOx) coupled to bovine serum
albumin (BSA), originally isolated from a human Ab
phage library [46]. The pFKPDN phagemid encodes
either the 4B2A1 [TRAV7D-3*01, TRAJ40*01/TRBV13-
2*01, TRBD1*01, TRBJ1-2*01] or 7A10B2 [TRAV9-3*01,
TRAJ58*01/TRBV19*01, TRBD1*01, TRBJ1-1*01]
scTCRs that have been described in detail previously
[32]. E. coli XL-1 Blue (recA1 endA1 gryA96 thi-1 hsdR17
supE44 relA1 lac [F’ proAB lacIqZΔM15 Tn10 (Tetr)] was
purchased from Stratagene (LaJolla, CA, USA).
Construction of the scTCR pHOG, pFKPEN and pFKPEI
expression vectors
The pHOG expression vectors (Figure 1A and 1B) were
generated by subcloning the scTCR encoding cassettes
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from pFKPDN phagmid into pHOG on compatible
NcoI/NotI RE sites using standard techniques, before
transformation into E. coli XL1-Blue cells. Likewise, the
pFKPEN expression vectors (Figure 1C and 1D) were
created by subcloning the FkpA expression cassette
from pFKPDN into these new vectors on compatible
ScaI/NheI RE sites. The fkpA gene is constitutively
expressed from its native promoter, xPO, in pFKPEN
(Figure 1C and 1D).
To generate an expression vector were FkpA tran-
scription is controlled by the lac promoter that also con-
trols the scTCR transcription, the pFKPEI expression
vector was made (Figure 1E and 1F). The genomic E.
coli K12 sequence (Accession no.: NC_000913) was used
for primer design to isolate the fkpA gene ORF. The for-
ward primer was designed with a 5’-end NheI tag fol-
lowed by the T7g10 TIR region [47] and the fkpA-
encoding portion (Additional file 1). The reverse primer
also included a 5’-end NhelI RE site and a FLAG tag
encoding sequence (Additional file 1). PCR was applied
to 1 μl of E. coli XL1-Blue overnight culture using Vent
DNA polymerase (New England Biolabs, Ipswich, MA,
USA). The resulting DNA fragment was ligated into
pHOG-Dummy [32] on the corresponding NheI RE site
creating the new pFKPEI-Dummy expression vector. To
generate the final pFKPEI expression vector (Figure 1E
and 1F), the NcoI/NotI scTCR segments were cloned
into this construct as described above, before transfor-
mation into E. coli XL1-Blue cells. The pFKPEI
expression vector (Figure 1E and 1F) contains a dicistro-
nic expression cassette with the scTCR open reading
frame (ORF) followed by a translation initiation region
(TIR) and the FkpA ORF, both controlled by the lac
promoter. All the constructs were validated by RE analy-
sis and subsequently confirmed by sequencing.
Protein production
E. coli XL1-Blue cells transformed with the plasmids
were inoculated from glycerol stocks into 5 ml LB-med-
ium supplemented with 30 μg/ml tetracycline, 100 μg/
ml ampicillin and 0.1 M glucose (LBTAG medium), in 50
ml tubes and incubated at 37°C/220-rpm overnight
(ON). The cultures were then re-inoculated into 5 ml
LBTAG medium at an OD600 nm of 0.025 in 50 ml tubes
and incubated at 37°C/220 rpm. At OD600 nm 0.6-0.8,
the bacteria were pelleted (3600-g/10 min/RT) and the
pellets resuspended in 5 ml LB medium supplemented
with 0.1 mM isopropyl-b-D-thio-galactopyranoside
(IPTG), 30 μg/ml tetracycline and 100 μg/ml ampicillin.
Cultures were then incubated at 30°C/250 rpm/ON. To
directly compare specific scTCR and FkpA protein pro-
duction from each clone, cell numbers were normalized
according to OD600 nm before being channelled into an
identical cellular compartment fractionation procedure.
The standard expression conditions described above
were varied such that the cultures were grown under
standard conditions until OD600 nm 0.6-0.8, pelleted and
resuspended in LB-medium supplemented with the
Figure 1 Schematic drawing of the scTCR molecules (left) and scTCR encoding vector constructs (right). (A) and (B) scTCR Vab and Vba
in pHOG. (C) and (D) scTCR Vab and scTCR Vba in pFKPEN. (E) and (F) scTCR Vab and Vba in pFKPEI. Abbreviations: lacPO, lac promoter, sd,
Shine-Dalgarno sequence, T7g10, translation initiation region, t, T7 transcription terminator, xPO, native fkpA promotor, NcoI, NotI, NheI and ScaI,
Restriction enzyme-sites.
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following additives, either 0.1 mM IPTG and 0.4 M
sucrose, 0.4 M sucrose or without any additives. Again,
cell numbers were normalized as above. An up-scaled
shaker flask production was performed in 400 ml
expression cultures without any additives for 4B2A1
scTCR Vab in pFKPEI, while 4B2A1 scTCR Vba in
pFKPEI was performed with 0.1 mM IPTG additive, in
2 L shaker flasks. 7A10B2 scTCR Vab and Vba in
pFKPEN was produced in several small scale cultures
(10 × 50 ml) without any additives. All cultures were
then subject to the cellular compartment fractionation
procedure.
Cellular compartment fractionation
Cells were harvested by centrifugation at 15 min/4600-g/
4°C and separated into; (1) medium fraction, (2) soluble
periplasmic fraction and (3) cytosolic fraction by a modi-
fied version of that described by Kipriyanov et al. [45].
Briefly, the medium fraction was obtained by an addi-
tional centrifugation of 1 ml supernatant (10 min/16,530-
g/4°C). To obtain the cytosolic and periplasmic fractions,
the pellet was resuspended in 490 μl ice-cold periplasmic
extraction solution (50 mM Tris/HCl, 20% sucrose, 1
mM EDTA, pH 8) supplemented with 5 μl lysozyme (100
mg/ml in 50 mM Tris/HCl, pH 8) and 5 μl RNase A (10
mg/ml in50 mM Tris/HCl, pH8) before incubation for 1
h at 4°C with rotation. The mixture was centrifuged, leav-
ing the soluble periplasmic fraction as the supernatant.
The pellet, containing the cytosolic fraction, was resus-
pended in 475 μl ice-cold 0.1 M Tris-HCl, pH 8, before
addition of 167 μl 4× sample buffer (200 mM Tris-HCl,
8% SDS and 40% glycerol) and subjected to rough pipet-
ting to dissolve the pellet. For the large scale (400-500
ml) cultures, the same fractionation procedure was used
after adjusting the reagent volumes × 80.
Protein purification
The periplasmic fractions isolated after 400-ml expres-
sion were diluted 1:3 in binding buffer (40 mM sodium
phosphate, 0.5 M NaCl, 40 mM imidazole, pH 7.4) and
filtered through a 0.2 μm sterile filter (Millipore). The
samples were purified by immobilized metal affinity
chromatography (IMAC) on a His-TrapHP column (GE
Healthcare Life Sciences) as described in the protocol
provided by the manufacturer. The eluted protein frac-
tions were pooled, concentrated by Amicon Ultra-15
Centrifugal Filter Units (Millipore) and dialyzed against
storage buffer (1× PBS, 500 mM NaCl, pH 6.5). Protein
concentration was determined by A280 nm on a Nano-
Drop ND-1000 apparatus (Thermo Fischer Scientific
Inc., Walmington, USA) based on calculated extinction
coefficients [48]. Size exclusion chromatography (Super-
dex 75 10/300 GL, GE Healthcare Life Sciences) was
performed on an automated ΔKTA chromatography
system, (GE Healthcare Life Sciences) using 70 μl of the
IMAC purified protein to isolate monomeric scTCR.
The concentration of protein in each fraction was deter-
mined as described above, followed by analysis on non-
reducing and reducing SDS-PAGE and western blotting
as described below. The monomeric fractions were
pooled, concentrated by Amicon Ultra-4 Centrifugal Fil-
ter Units (Millipore) followed by concentration determi-
nation as before.
SDS-PAGE and western blotting
Identical volumes of fractionated samples isolated in
parallel from A600 nm normalized E. coli cell cultures
were separated by non-reducing SDS-PAGE on 4-12%
Bis-Tris XT precast gels (Bio-Rad, Hercules, CA, USA)
and blotted onto a polyvinylidene fluoride membrane
(Millipore, Madison, USA) in Tris/glycine buffer (25
mM Tris, 192 mM Glycine, and 20% methanol, ph 8.3)
at 25 V for 30 min using a semi-dry blotting apparatus
(Bio-Rad, Hercules, CA, USA). The membrane was
blocked in PBSTM (1× PBS supplemented with 0.05% v/
v Tween 20 and 4% w/v skim milk) before scTCR pro-
teins were detected with anti His-HRP Ab (1:10, 000).
The membrane was washed and developed with Super-
Signal™ West Pico substrate (Pierce, Rockford, IL, USA)
before exposed to BioMax MR film (Kodak, Fernwald,
Germany). Expression of rFkpA was detected after 30
min stripping by Restore™ Western Blot Stripping Buffer
(Pierce, Rockford, IL, USA), and the membrane redeve-
loped as above using an anti-FLAG M2-HRP Ab (1:10
000). Samples of 0.25 μg Superdex 75 purified scTCRs
were analyzed in parallel with 0.25 μg IMAC purified
scTCRs by non-reducing and reducing SDS-PAGE fol-
lowed by western blotting as described above.
scTCR capture ELISA
The various mAbs were absorbed to MaxiSorp microtiter
plate wells (Nunc, Roskilde, Denmark) at a concentration
of 5 μg/ml in 1 × PBS, pH 7.4 ON at 4°C. The wells were
blocked with PBSTM for 1 h at RT, and IMAC purified
scTCR samples at a concentration of 4 μg/well and
Superdex75 purified scTCR samples at a concentration
of 0.4 μg/well were added. All were allowed to react for
2 h at RT before the captured scTCRs were detected
with anti-His-HRP Ab (1:5000) for 2 h at RT. The wells
were developed with 100 μl of TMB soluble substrate
(Calbiochem), stopped by adding 1 M HCl after 30 min,
and the absorbance read at A450 nm.
Circular dichroism (CD) spectroscopy
CD spectra were recorded using a Jasco J-810 spectro-
polarimeter (Jasco International Co., Ltd., Tokyo Japan).
Measurements were performed at 25°C using a quartz
cuvette (Starna, Essex, UK) with a path length of 0.1
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cm. Measurements were performed with a protein con-
centration of 0.120 mg/ml for 4B2A1 scTCR Vab and
0.150 mg/ml for the control scFv Ab fragment in 1×
PBS, supplemented with 500 mM NaCl (pH 6.4). Sam-
ples were scanned 5 times at 50 nm/min, using a band
width of 1 nm. The response time was 2 s, and the
wave length range was 200-260 nm. The data were aver-
aged and the spectrum of a sample-free control was
subtracted. The secondary structure elements of the
proteins were calculated from ellipticity data, using the
spectral fitting methods, CONTIN/LL [49], SELCON3
[50] and CDSSTR [51], in the CDpro package [52].
Thermal denaturation was determined as the change in
CD signal from heating. The temperature was controlled
with a TPC-423S/L system (Jasco International Co).
Secondary structure prediction
Secondary structure element of the 2C TCR structure
(PDB:2oi9) [53] were predicted using the DSSP [54] and
Stride[55].
Results
Construct design
The pHOG (Figure 1A, B), pFKPEN (Figure 1C, D) and
pFKPEI (Figure 1E, F) vectors drive scTCR expression
from the lac promoter. In all cases, the scTCRs are
fused to an N -terminal pelB signal sequence that
directs protein translocation across the inner membrane
of E. coli through the SecB-dependent pathway to the
oxidising environment of the periplasm. This oxidising
environment is a prerequisite for generation of disul-
phide bridges within proteins such as scTCRs [56,57].
The pFKPEN and pFKPEI vectors also carry the gene
encoding the periplasmic chaperone FkpA. In pFKPEN,
recombinant FkpA (rFkpA) expression is controlled by
its native promoter, while pFKPEI contains a dicistronic
expression cassette where rFkpA gene transcription is
controlled by the lac promoter.
In all vectors, the scTCR cassette was constructed by
genetically fusing Va and Vb encoding gene segments
with a sequence encoding a synthetic linker [44]. To
gain insight into how domain orientation affects soluble
expression, two versions with alternative domain orien-
tation were made, such that either Va (Figure 1A, C and
1E) or Vb (Figure 1B, D and 1F) was expressed N-term-
inally. All scTCRs were fused to a c-Myc- and a His-tag
C-terminally, whilst rFkpA was fused to a C-terminal
FLAG-tag. All constructs used in the current study are
described in Figure 1.
Expression level and subcellular localization
Expression was performed in E. coli XL1-Blue followed by
cell fractionation and periplasmic expression analyzed by
SDS-PAGE and Western blotting, as described in the
Method section. As shown in Figure 2, 4B2A1 scTCR was
not detected in the periplasmic fraction using anti-tag
mAbs in the absence of rFkpA over-expression (pHOG-
plasmids), regardless of domain orientation and expression
conditions. The 7A10B2 scTCR behaved like 4A10B2 (Fig-
ure 3). Thus, both scTCRs failed to reach the periplasmic
space, and rather aggregated in the cytosol (results not
shown). The growth characteristics of each culture were
studied and the results are summarized in Table 1. The
one expressing 4B2A1 Vab scTCR showed sign of growth
arrest. All others demonstrated overall robust growth and
reached a final cell density similar to that of the XL1-Blue
control without plasmid.
The chaperone FkpA has a highly beneficial effect on
periplasmic expression and correct folding of toxic Ab
scFvs, [27], and we have recently reported a similar effect
on phage display of scTCRs [32]. Thus, the effect of
FkpA over-expression was assessed here. The clones that
were picked for further study, all expressed high levels of
FkpA as demonstrated by SDS-PAGE and western blot of
whole cell lysates using anti-Flag Ab (results not shown).
The periplasmic levels of scTCRs in both configura-
tions, Vab and Vba, were detected under different
expression conditions. The levels of rFkpA in the peri-
plasm were also assessed. When expression was induced
with IPTG, a high yield of 4B2A1 scTCR in Vba orien-
tation was observed, while scTCR with the opposite
Vab orientation was not (Figure 2A). The highest yield
of 4B2A1 Vba scTCR was obtained when rFkpA tran-
scription was under lac promoter control. All four of
these 4B2A1 scTCR producing cultures (Vab and Vba
from pFKPEN and pFKPEI) showed robust growth
(Table 1). The 7A10B2 scTCR was not detected or
detected in negligible amounts in the periplasmic frac-
tion regardless of orientation (Figure 3A). The scTCR
Vab producing culture showed sign of growth arrest
when rFkpA was transcribed from its endogenous pro-
moter (Table 1).
It has earlier been reported that a reduction of the
IPTG concentration has a positive effect on periplasmic
yield of soluble protein expressed from a lac promoter
[45]. Indeed, when expression was performed without
IPTG, the periplasmic yield of 4B2A1 Vab increased
considerably. The yield of 4B2A21 Vba, on the other
hand, decreased (Figure 2B). The yield of 7A10B2
scTCR in both domain orientations increased (Figure
3B). All cultures reached high and similar final cell den-
sity (Table 1). Analysing periplasmic FkpA levels, this
was equal to or higher than that observed in the pre-
sence of IPTG in all cases, except when expressed from
the lac promoter in the vector encoding 4B2A1 scTCR
Vba. This was in line with the fact that very little
4B2A1 scTCR Vba was found in the periplasmic space
in the absence of induction.
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Addition of 0.4 M sucrose to the growth medium has
been shown to increase the yield of secreted proteins,
either in the periplasm or culture medium [45,58]. To
investigate if the soluble scTCR yield in the periplasmic
fraction could be further increased, the effect of sucrose
addition was assessed both in uninduced and IPTG
induced cultures. Neither the 4B2A1 (Figure 2C and
2D) nor 7A10B2 (Figure 3C and 3D) scTCR levels
increased after sucrose addition. The expression patterns
were identical to that observed without sucrose addition,
and no increased leakage to the culture medium was
observed (data not shown).
Taken together, overall good yields of periplasmic
4B2A1 scTCR were seen in the presence of periplasmic
rFkpA expression. This was observed from both
pFKPEN and pFKPEI plasmids; for Vab, when expres-
sion was performed in the absence of IPTG and for
Vba, when expression was performed in the presence of
IPTG. For 7A10B2 scTCR, the overall highest yield was
seen from the pFKPEN plasmid in the absence of IPTG
for both the Vab and the Vba configuration.
Protein purification
The four scTCR variants, 4B2A1 and 7A10B2 in both
domain orientations, were expressed at large scale
under conditions shown to give good small scale peri-
plasmic yields. Protein fractionation was performed as
described above, followed by IMAC purification. Eluted
fractions containing protein were pooled and concen-
trated. The production yields after concentration is
given in Table 2 and were 3.6 and 3.9 mg/l for the
4B2A1 Vab and Vba variants, respectively. Very low
yield of the 7A10B2 variants were obtained. Thus, the
two 4B2A1 samples only were further analyzed by size
Figure 2 4B2A1 scTCR and rFkpA expression level. Western blot showing periplasmic expression levels of 4B2A1 scTCR variants and rFkpA
from pHOG, pFKPEN (pEN) and pFKPEI (pEI) vectors under different expression conditions, detected with anti-His tag -HRP Ab and anti-Flag- M2
HRP Ab as described. The scTCR and rFkpA were developed with SuperSignal West Pico substrate and exposed to BioMax MR film for for 30 min
and 30 sec, respectively, for the upper and lower panels. The expression analysis was repeated twice, and representative results are shown.
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Figure 3 7A10B2 scTCR and rFkpA expression level. Western blot showing periplasmic expression levels of 7A10B2 scTCR variants and rFkpA
from pHOG, pFKPEN (pEN) and pFKPEI (pEI) vectors under different expression conditions, detected with anti-His tag-HRP and anti-Flag-M2-HRP
as described. The scTCR and rFkpA were developed with SuperSignal West Pico substrate and exposed to BioMax MR film for for 30 min and 30
sec, respectively, for the upper and lower panels. The expression analysis was repeated twice, and representative results are shown.
Table 1 Growth characteristicsa
TCR format Vector +IPTG -IPTG +Sucrose +IPTG
+Sucrose
4B2A1 scTCR Vab pHOG 0.6b 2.6 1.36 0.48b
pFKPEN 3 2.8 2.2 2.2
pFKPEI 2.8 2.8 2.1 2.4
4B2A1 scTCR Vba pHOG 2.6 2.6 2.2 2.2
pFKPEN 2.8 3 2.5 2.4
pFKPEI 2.7 2.8 2.2 2.2
7A10B2 scTCR Vab pHOG 3 3 2.6 2.4
pFKPEN 0.8b 2.8 2.2 0.58b
pFKPEI 2.8 2.6 1.8 2
7A10B2 scTCR Vba pHOG 3 3 2.4 0.48b
pFKPEN 2.8 2.8 2.3 2.6
pFKPEI 2.8 2.8 2 2.2
XL1-Blue cells without plasmid 2.8 2.8 2 2.2
a A 600 nm after ON incubation of 5 ml expression cultures
b No growth of cultures after induction
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exclusion chromatography (Superdex 75 GL 10/300)
(Figure 4A and 4B), followed by non-reducing and
reducing SDS-PAGE of eluted fractions (Figure 4C and
4D). Importantly, the Vab format had more than dou-
ble the amount of monomeric scTCR compared to the
Vba format (Figure 4A and 4B, and table 2). However,
both formats were produced as polymers that appeared
to be composed of both non-covalent and covalent
aggregates (Figure 4C and 4D). Taken together, the
overall best yield of monomeric scTCR was from the
4B2A1 clone in the Vab orientation. This format
yielded 2.1 mg per L culture of active purified mono-
meric material, which is comparable with or better
than amounts acquired by others using periplasmic
expression systems (table 2) [26,9]. Importantly, the
huC fusion format reported by Maynard et al [9]
requires downstream proteolytically removal of the
huC moiety, hence the actual soluble scTCR yield
will be equal to or lower than with our approach.
Moreover, the absence of this huC fusion resulted in
wastely reduced scTCR yield (table 2) [9].
Figure 4 Purity of proteins. (A) and (B); S75 size exclusion chromatography of scTCR 4B2A1 Vab and Vba respectively. 50 μl of the IMAC
purified material was subject to the purification procedure. In (A) fractions A14-B1 corresponds to the higher aggregates, while fraction B5-B7
corresponds to the monomeric scTCR 4B2A1 Vab, the monomeric fraction is highlighted with an arrow. In (B) fraction A15-B1 and B3-B4
corresponds to the higher aggregates, while fraction B6-B7 corresponds to the monomeric scTCR 4B2A1 Vba, the monomeric fraction is
highlighted with an arrow. (C) and (D); Western blots showing reduced and non-reduced scTCR Vab and Vba after IMAC purification and S75
size exclusion chromatography. Samples of 0.25 μg were loaded on the gel and analysed with anti-His tag-HRP.
Table 2 Production yield
TCR
format
Total soluble production
yield mg/L culturea
Soluble monomeric
production yield mg/L
cultureb
4B2A1
scTCR Vab
3.6 2.1
4B2A1
scTCR Vba
3.9 0.44
7A10B2
scTCR Vab
0.78 ND
7A10B2
scTCR Vba
0.24 ND
1934c ND 3.8
c19c ND 3
2B4c ND 0.5
2B4d ND 0.015
a Estimated periplasmic yield of total soluble scTCRs after IMAC purification.
b Estimated periplasmic yield of monomeric soluble scTCR after size exclusion
chromatography.
c Values implemented from Maynard et al [9], scTCR-human C kappa fusion
format
d Values implemented from Maynard et al [9], scTCR format
ND; Not determined
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Folding and secondary structure analysis
ELISA
The conformational integrity of the IMAC and size
exclusion chromatography purified 4B2A1 scTCRs was
analyzed using two V-gene specific mAbs in a capture
ELISA. Furthermore, 7A10B2 scTCRs were produced
in several parallel small scale cultures, that were
pooled, IMAC purified and analyzed in capture ELISA.
The results show that differences exist in mAb reac-
tivity between the scTCRs with regard to domain
orientation. For both 4B2A1 and 7A10B2 scTCR, the
Vab scTCRs exhibited stronger mAb reacitivity than
the Vba counterparts (Figure 5A and 5B). Both anti-
Vb8 MAb F23.1 and clonotype-specific GB113 bound
the purified 4B2A1 scTCRs fractions (Figure 5A).
GB113 bound the two molecules equally well, whilst
F23.1 bound better to Vab than to Vba, Likewise, the
IMAC purified 7A10B2 Vab scTCR was detected by
the Vb6-specific 44-2-1 and RR4-7 MAbs, whereas no
binding was observed in the Vba domain orientation
(Figure 5B).
Structural analysis by CD spectroscopy
scTCR Vab 4B2A1 and a control scFv Ab fragment
were subjected to CD spectroscopy at 20°C and 56°C as
shown in Figure 6, and the spectra obtained analyzed
using CONTIN/LL [49], SELCON3 [50] and CDSSTR
[51]. The obtained structure data from the three fitting
techniques were similar. However, CONTIN/LL gave
slightly lower RMSD ratios than CDSSTR. The results
from CONTIN/LL are thus given in Table 3. The CD
data analysis indicated a 47% and 42% b-sheet content
as well as a 5% and 5% a-helix content in the scFv
control and 4B2A1 scTCR Vab molecules, respectively.
The spectra of both 4B2A1 scTCR Vab (Figure 6A) and
the control scFv Ab fragment (Figure 6B) are hence
typical of a protein with high degree of b-sheet structure
characteristic for the Ig-fold. This is consistent with the
secondary structure element prediction given by DSSP
[54] and Stride [55] for the 2C TCR structure (PDB:
2oi9) [53], which calculates a 49% b-sheet content and a
a-helix content of 4.5%. The degree of secondary struc-
ture content decreased as the temperature was raised
towards 56°C as seen in Table 3 and Figure 6C, indicat-
ing thermally induced unfolding of the protein.
Discussion
The aim of the current study was to generate a general
expression system for soluble scTCRs. The 4B2A1 and
7A10B2 scTCRs used have previously been successfully
expressed as fusions to pIII on filamentous phage [32].
Based on that study, the current report focuses on the
soluble scTCR format and investigation of protein yield
and sub-cellular localization using a bacterial system
compatible with the E. coli host used in scTCR phage
display, namely XL1-Blue.
Chaperones are known to enhance expression yields as
they facilitate folding, prevent aggregation, reactivate
aggregates and reduce protein degradation [28,59-61].
Bothmann and Plückthun [23,27] identified two periplas-
mic factors, namely FkpA and Skp, which increased the
functional periplasmic yields of toxic Ab scFvs, while
already well-expressing clones were unaffected. FkpA is a
periplasmic peptidyl-propyl cis,trans-isomerase, but the
effect was also striking for scFvs that did not contain cis-
Figure 5 Integrity analysis of scTCR. A) ELISA analysis of equal amount of purified 4B2A1 scTCR captured on TCR V-gene specific mAbs. B)
ELISA analysis of equal amount of purified 7A10B2 scTCR captured on TCR V-gene specific MAbs. One of two independent experiments
performed in duplicates is shown with the SD indicated as error bars.
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prolines. The positive effect rather seemed to be a result
of the ability of the chaperone to prevent premature
aggregation of early folding intermediates as well as reac-
tivation of inactive proteins [28,62]. Skp belongs to a
family of cavity-containing chaperons and works by pro-
tecting its substrate from aggregation within this cavity
[63]. Skp was recently reported to have an effect on
scTCR expression [9]. However, co-expression of Skp
and FkpA showed no synergistic effect on scFv yield.
Rather, co-expression had the same effect as FkpA alone
[27]. We have previously reported that over-expression
of rFkpA normalized the display level of scTCRs-pIII
fusions in phage display, while Skp had only minor effects
[32]. In the present study, we therefore focused on FkpA
co-expression.
Without chaperone co-expression, the scTCRs were
trapped in the cytosol despite the fact that all constructs
were equipped with a pelB leader sequence directing
transport to the periplasm. When FkpA was co-
expressed, we observed a positive effect on growth rate.
Moreover, a profound effect on the accumulation of
soluble 4B2A1 and 7A10B2 scTCRs in the periplasm
was also seen. This was the case whether rFkpA was
expressed from its native promoter or the lac promoter.
These initial results hence showed that FkpA has an
ability to significantly increase the periplasmic expres-
sion yield of the TCRs.
The effect of domain orientation on functional scTCR
fragments has been reported earlier, and show the same
trend as we see here, namely that the Va-linker-Vb
domain orientation increases the functional fraction of
scTCR fragments [32,64]. Generally, the most unstable
fragment should be put N-terminally and the most
stable fragment C-terminally. This prevents rapid folding
of the N-terminal domain followed by abortive periplas-
mic translocation caused by a partly unfolded C-term-
inal domain [32,64]. The TRBV13-2 segment used in
the 4B2A1 scTCR, is considered a particularly stable
fragment [65,66]. The results in this report hence fit
well with the results obtained by others.
Culture conditions, such as induction and growth in
the presence of certain sugars, have been shown to
influence the production yield and sub-cellular localiza-
tion of proteins [45,58,67]. We therefore investigated
the effect of sucrose addition to the medium as well as
the effect of adding or removing IPTG. The results
showed that 4B2A1 TCR in the Vba orientation was
expressed well under standard conditions, that is, in the
presence of IPTG, but without addition of sugars. In
contrast, 4B2A1 TCR Vab and 7A10B2 in both domain
orientations were expressed poorly. Removal of IPTG
from the growth medium restored the expression of
these three molecules. Without IPTG residual transcrip-
tion still occurs through the leaky lac promoter, but
Figure 6 Circular dichroism spectra of the purified scTCR Vab
protein (A) and a control scFv Ab fragment (B) collected at 20°
C. CD scans at two different temperatures, 20°C and 56°, are shown
in (C). MRE, mean residual ellipicity.
Table 3 Secondary structure elementsa
scFv at 20°C scTCR at 20°C scTCR at 56°C
a-Helix 5 5 5
b-Sheet 47 42 20
b-Turn 20 21 20
Random coil 28 32 39
a The secondary structure elements were estimated by CONTIN/LL from the
CD spectrums presented in Figure 6. The experiment was repeated twice, and
representative results are shown.
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with decreased translation and hence folding load. This
was found to be beneficial for the scTCRs.
It has previously been reported that growing cells in
the presence of certain sugars, raffinose or sucrose, can
reduce the aggregation of recombinant proteins in the
E. coliperiplasm [45,58]. These sugars are small enough
to diffuse through the inner membrane to the periplasm,
causing an increase in the osmotic pressure resulting in
enlargement of the periplasmic space, and hence a
decrease in the local protein concentration [45,68].
However, the addition of sucrose had no effect on the
yield of scTCR in the periplasm. Possibly, the over-
expression of rFkpA prevents premature aggregation so
efficiently that the addition of sucrose has little or no
detectable effect.
When large scale expression using optimalized expres-
sion conditions for each of the scTCRs was performed
mg/L amounts were obtained from both 4B2A1 scTCRs
after purification. The 7A10B2 derived scTCRs showed
an altered expression profil after up-scaling, which has
also been reported by others for antibody scFv frag-
ments [45]. However, by pooling the periplasmic frac-
tion from several small scale cultures, yields of μg/L
were obtained. Thus, the 4B2A1 derived molecules only
were chosen for studies of how domain orientation
influences the yield of the monomeric fraction as well as
folding. We found that the scTCR with the Vab domain
orientation had a larger monomeric peek than the one
with the Vba domain orientation. Aggregates appeared
to be formed after misfolding due to erroneous disul-
phide bond formation as well as through surface
exposed hydrophobic patches.
The affinity of the monomers for their cognate pMHC
(l2315/I-Ed) ligand, is too low for detection by flow cyto-
metry. We therefore used binding to several well charac-
terized MAbs as an indirect measurement of structural
integrity and functionality. The same MAbs have been
used earlier to characterize the same scTCRs displayed
on phage [32] or expressed as TCR-Ig fusions (manu-
script submitted). In both cases, binding to MAbs corre-
lated with the ability of the TCR moiety to bind I-Ed
expressing murine A20 lymphoma cells that had been
loaded with the cognate l2315 peptide, and binding
required a multivalent format (three-five copies on
phage and two copies in the TCR-Ig fusion) [32].
Importantly, the current report shows differences in
MAb reactivity with regard to domain orientation, and
the Vab format was superior to the Vba format.
Furthermore, the secondary structure data given by CD
measurements shows that the scTCR Vab has a native-
like fold that in conjunction with the binding activity of
the MAbs strongly indicates functionality.
Conclusion
The work demonstrated that the presence of the chaper-
one FkpA, expression conditions as well as domain
orientation greatly influence the yield and sub-cellular
localization of soluble TCRs. Over-expression of FkpA
in the periplasm is a prerequisite for soluble periplasmic
localization of the scTCR, and absence of inducer
(IPTG) further improved the periplasmic yield of for-
mats which were poorly expressed under standard con-
ditions. Addition of sucrose to the medium did not
influence the yield. Comparing scTCR molecular design,
the format with Vab domain orientation gives a better
expression profile with regard to monomeric protein
yield than the Vba format, and the binding to specific
MAbs is stronger. Furthermore, the purified 4B2A1
scTCR Vab exhibited well resolved secondary structure
elements typical for the Ig fold topology indicating a
correctly folded TCR moiety. The final protein yields
obtained using our optimized approach perform equal
or better than previously reported periplasmic expres-
sion systems and this was achieved without fusions or
aa modifications of the TCR moiety. We anticipate that
this system may enable rapid production of a wide
range of soluble TCRs, and thereby simplify the screen-
ing of a new generation of recombinant TCRs generated
by protein engineering and display techniques such as
phage-display.
Additional file 1: Primer overview. Primers used to isolate the fkpA
gene ORF.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1472-6750-10-8-
S1.DOC ]
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